George L. Sing, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 27,000 shares at $285.29 ($7.7M) on 2018-05-09, disclosed to the SEC on 2018-05-11.
Open-market sale of $7.7M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $285.29 | 7,000 | $2.0M | 25.9% |
| 2 | $285.29 | 7,000 | $2.0M | 25.9% |
| 3 | $285.00 | 3,000 | $855K | 11.1% |
| 4 | $286.00 | 3,000 | $858K | 11.1% |
| 5 | $287.00 | 3,000 | $861K | 11.2% |
| 6 | $288.00 | 4,000 |
| $1.2M |
| 14.9% |
| Total | $285.93 avg | 27,000 | $7.7M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |